Clozapine: progress in treating refractory schizophrenia.
- 29 May 1993
- Vol. 306 (6890) , 1427-1428
- https://doi.org/10.1136/bmj.306.6890.1427
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Assessment of Costs and Benefits of Drug Therapy for Treatment-Resistant Schizophrenia in the United KingdomThe British Journal of Psychiatry, 1993
- Psychopharmacology and the Ethics of Resource AllocationThe British Journal of Psychiatry, 1993
- Clinical and Biologic Response to Clozapine in Patients With SchizophreniaArchives of General Psychiatry, 1992
- Dopaminergic and serotonergic effects of clozapine. Implications for a unique clinical profile.1992
- ClozapineDrugs, 1990
- Effects of Six Months of Clozapine Treatment on the Quality of Life of Chronic Schizophrenic PatientsPsychiatric Services, 1990
- Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophreniaPsychopharmacology, 1989
- Clozapine for the Treatment-Resistant SchizophrenicArchives of General Psychiatry, 1988
- The effect of long‐term treatment with clozapine in schizophrenia: A retrospective study in 96 patients treated with clozapine for up to 13 yearsActa Psychiatrica Scandinavica, 1988